Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

April 2006

Volume 12, Issue 4

Pages 251–338

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Clinical Reviews
    4. Letters to the Editor
    1. 5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine (pages 251–257)

      Scott Hande, Noah Wilson-Rich, Athos Bousvaros, Anna Zholudev, Rie Maurer, Peter Banks, Frederick Makrauer, Sarathchandra Reddy, Robert Burakoff and Sonia Friedman

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000206544.05661.9f

    2. Indeterminate colitis: A significant subgroup of pediatric IBD (pages 258–262)

      Ryan S. Carvalho, Vivian Abadom, Harrison P. Dilworth, Richard Thompson, Maria Oliva-Hemker and Carmen Cuffari

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215093.62245.b9

    3. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and Inflammatory Bowel Disease and their effects on disease behavior: A case-control and meta-analysis study (pages 263–271)

      Clive M. Onnie, Sheila A. Fisher, Reenal Pattni, Jeremy Sanderson, Alastair Forbes, Cathryn M. Lewis and Prof. Christopher G. Mathew

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209791.98866.ba

    4. CC-Type chemokine receptor 5-Δ32 mutation protects against primary sclerosing cholangitis (pages 272–277)

      Dr. Liesbet Henckaerts, Johan Fevery, Werner Van Steenbergen, Chris Verslype, Paul Yap, Frederik Nevens, Tania Roskams, Louis Libbrecht, Paul Rutgeerts and Séverine Vermeire

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209790.21737.28

    5. Unique dietary-related mouse model of colitis (pages 278–293)

      Harris Bernstein, Hana Holubec, Carol Bernstein, Natalia Ignatenko, Eugene Gerner, Katerina Dvorak, David Besselsen, Lois Ramsey, Monique Dall'Agnol, Karen Ann Blohm-Mangone, Jose Padilla-Torres, Haiyan Cui, Harinder Garewal and Claire Margaret Payne

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209789.14114.63

    6. Pain and mechanical properties of the rectum in patients with active ulcerative colitis (pages 294–303)

      Prof Asbjørn Mohr Drewes, Jens Brøndum Frøkjær, Ejnar Larsen, Hariprasad Reddy, Lars Arendt-Nielsen and Hans Gregersen

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209365.09189.04

    7. Predicting the Crohn's disease activity index from the harvey-bradshaw index (pages 304–310)

      William R. Best

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215091.77492.2a

  2. Clinical Reviews

    1. Top of page
    2. Original Articles
    3. Clinical Reviews
    4. Letters to the Editor
    1. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD (pages 311–327)

      Jolanda M. van Dieren, Ernst J. Kuipers, Janneke N. Samsom, Edward E. Nieuwenhuis and C. Janneke van der Woude

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209787.19952.53

    2. Outcomes of placebo therapy in inflammatory bowel disease (pages 328–333)

      Chinyu Su

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215094.69869.2e

  3. Letters to the Editor

    1. Top of page
    2. Original Articles
    3. Clinical Reviews
    4. Letters to the Editor
    1. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine (pages 334–335)

      Sara García-Morán, Federico Sáez-Royuela, Juan-Carlos Pérez-Álvarez, Elena Gento and José Téllez

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000209788.19952.b7

    2. Rifaximin for active ulcerative colitis (page 335)

      Mario Guslandi, Maria Chiara Petrone and Pier Alberto Testoni

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215092.85116.6c

    3. Role of infliximab in ulcerative colitis: Further questions (pages 335–337)

      Charles W. Lees, Alan G. Shand, Ian D. Penman, Jack Satsangi and Ian D.R. Arnott

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215095.69869.67

    4. Successful infliximab therapy for oral Crohn's disease (pages 337–338)

      H. Cardoso, A.C. Nunes, F. Carneiro and F. Tavarela Veloso

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/01.MIB.0000215096.51943.82

SEARCH

SEARCH BY CITATION